277 related articles for article (PubMed ID: 2545780)
1. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
Dubois C; Bissonnette E; Rola-Pleszczynski M
J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
[TBL] [Abstract][Full Text] [Related]
2. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages.
Thivierge M; Rola-Pleszczynski M
J Allergy Clin Immunol; 1992 Nov; 90(5):796-802. PubMed ID: 1331218
[TBL] [Abstract][Full Text] [Related]
4. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene B4.
Dubois CM; Bissonnette E; Rola-Pleszczynski M
Am Rev Respir Dis; 1989 May; 139(5):1257-64. PubMed ID: 2540688
[TBL] [Abstract][Full Text] [Related]
5. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages.
Berdeli A; Akisu M; Dagci T; Akisu C; Yalaz M; Kultursay N
Prostaglandins Leukot Essent Fatty Acids; 2004 Oct; 71(4):227-32. PubMed ID: 15301793
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.
Poubelle PE; Gingras D; Demers C; Dubois C; Harbour D; Grassi J; Rola-Pleszczynski M
Immunology; 1991 Feb; 72(2):181-7. PubMed ID: 2016118
[TBL] [Abstract][Full Text] [Related]
7. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells.
Weber C; Aepfelbacher M; Haag H; Ziegler-Heitbrock HW; Weber PC
Eur J Immunol; 1993 Apr; 23(4):852-9. PubMed ID: 7681399
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
Levine L
Mol Pharmacol; 1988 Dec; 34(6):793-9. PubMed ID: 2849046
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor provokes release of mucin-like glycoproteins from guinea pig respiratory epithelial cells via a lipoxygenase-dependent mechanism.
Adler KB; Akley NJ; Glasgow WC
Am J Respir Cell Mol Biol; 1992 May; 6(5):550-6. PubMed ID: 1316134
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity.
Sato E; Koyama S; Nomura H; Kubo K; Sekiguchi M
J Immunol; 1996 Oct; 157(7):3122-9. PubMed ID: 8816423
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
Warren JS; Barton PA; Mandel DM; Matrosic K
Lab Invest; 1990 Dec; 63(6):746-54. PubMed ID: 2255183
[TBL] [Abstract][Full Text] [Related]
14. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells.
Rola-Pleszczynski M; Pouliot C; Turcotte S; Pignol B; Braquet P; Bouvrette L
J Immunol; 1988 May; 140(10):3547-52. PubMed ID: 2834440
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of pulmonary natural killer cell activity by platelet activating factor. Mechanisms of activation involving Ca2+, protein kinase C, and lipooxygenase products.
Thivierge M; Rola-Pleszczynski M
Am Rev Respir Dis; 1991 Aug; 144(2):272-7. PubMed ID: 1650153
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
Zhang F; Decker K
Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of inducible cyclooxygenase gene expression by platelet-activating factor in activated rat alveolar macrophages.
Thivierge M; Rola-Pleszczynski M
J Immunol; 1995 Jun; 154(12):6593-9. PubMed ID: 7759893
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines.
He W; Pelletier JP; Martel-Pelletier J; Laufer S; Di Battista JA
J Rheumatol; 2002 Mar; 29(3):546-53. PubMed ID: 11908571
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
He J; Bazan HE
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
[TBL] [Abstract][Full Text] [Related]
20. Characterization of platelet-activating factor receptors on canine T lymphocytes.
Mangino MJ; Murphy MK; Weiss A; Anderson CB
J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
